Sinovac regimen gets strong boost from Pfizer, AstraZeneca or J&J COVID shots – study

  • Medical
  • January 25, 2022
  • 0 Comments
Published by
Reuters

(Reuters) -A third booster dose of a COVID-19 vaccine made by AstraZeneca, Pfizer-BioNTech or Johnson & Johnson increases antibody levels significantly in those who have previously received two doses of Sinovac’s CoronaVac shot, a study has found. The study found that CoronaVac received the strongest boost from a viral vector or RNA shot, including against the Delta and Omicron coronavirus variants, researchers from Brazil and Oxford University said https://www.ox.ac.uk/news/2022-01-24-mixed-vaccine-schedules-offer-strong-booster-responses-after-two-doses-coronavac on Monday. China-based Sinov…

Read More

  • Related Posts

    PM calls to boost anti-tuberculosis efforts

    Hanoi: Prime Minister Pham Minh Chinh recently ordered efforts to be exerted to enhance the tuberculosis (TB) prevention and control efforts.

    His recent dispatch in this regard said TB prevention and control activities have achieved commendable resul…

    Vietnamese blood donors save life of UK patient

    HCM City: Three Vietnamese donors with a rare blood type have helped save the life of a 64-year-old British man with immune thrombocytopenic purpura (ITP).

    The man was taken to Cho Ray Hospital in Ho Chi Minh City for emergency treatment on March 17….

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.